RELAPSING FORMS OF MULTIPLE SCLEROSIS
Clinical trials for RELAPSING FORMS OF MULTIPLE SCLEROSIS explained in plain language.
Never miss a new study
Get alerted when new RELAPSING FORMS OF MULTIPLE SCLEROSIS trials appear
Sign up with your email to follow new studies for RELAPSING FORMS OF MULTIPLE SCLEROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Real-World data shows MS Drug's impact on relapses and daily life
Disease control CompletedThis study looked at how well the multiple sclerosis (MS) treatment ofatumumab (brand name Kesimpta) worked for people in everyday Spanish clinics, not just in controlled trials. It followed 310 adults with relapsing MS who had been on the treatment for at least a year. The main …
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
MS drug trial halted after initial safety check
Disease control CompletedThis study tested a new oral drug, BIIB091, for people with relapsing forms of multiple sclerosis (MS). In the first part, 127 participants took either BIIB091 or an approved MS drug (diroximel fumarate) to check safety. The goal was to see if BIIB091, alone or combined with the …
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Phase: PHASE2 • Sponsor: Biogen • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New MS drug safety checked in asian patients
Disease control CompletedThis study tested the safety and how the body processes the drug diroximel fumarate in adults with relapsing forms of multiple sclerosis (MS) from the Asia-Pacific region. It involved 136 participants who took the drug for either 24 or 48 weeks. The main goal was to see how well …
Matched conditions: RELAPSING FORMS OF MULTIPLE SCLEROSIS
Phase: PHASE3 • Sponsor: Biogen • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC